Women's health, closing the gap with deeptech
An evening bringing together researchers, deeptech startups, pharma and investors to close the women’s health gap.
Less than 1% of global research and innovation funding is dedicated to women’s health, and women remain underrepresented in clinical trials. This structural gap leads to delayed diagnoses, lower treatment efficacy and higher rates of adverse side effects.
Deeptech innovations are opening new paths to better understand female biology and develop more precise diagnostics and therapies. Yet moving these breakthroughs from the lab to patients remains a major challenge.
Bringing women’s health innovation to market requires a coordinated ecosystem — researchers, pharmaceutical companies, investors, incubators and entrepreneurs — working together toward a shared ambition.
This event brings together key players across this value chain to explore one central question: what does it take to successfully translate women’s health innovation from research to real-world impact?
[The event will be held entirely in French]
Agenda :
18h30 — Doors Open
Arrival, welcome drinks and first connections
19h — Opening Keynote
Fatoumata Ly (CEO, Ninti)
19h15 — Panel Discussion "Demystifying Women’s Health"
With Elodie Chapel (CEO, Elixir), María Teresa Pérez Zaballos (CEO, Endogene), Gabrielle Fourchon (Corporate Affairs Director, Organon), and Molly Ingersoll (PhD, Directeur de Recherche à l'Institut Pasteur & Institut Cochin)
20h — Artistic Performance
A moment to pause, reconnect and shift perspectives
20h15 — Networking Cocktail
Conversations across research, startups, pharma and investment.